Federation des caisses Desjardins du Quebec’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-465
Closed -$1.58K 2184
2018
Q3
$1.58K Hold
465
﹤0.01% 2008
2018
Q2
$1.75K Hold
465
﹤0.01% 2031
2018
Q1
$1.9K Hold
465
﹤0.01% 1999
2017
Q4
$2.16K Hold
465
﹤0.01% 1989
2017
Q3
$3.3K Hold
465
﹤0.01% 1894
2017
Q2
$3.36K Buy
+465
New +$2.91K ﹤0.01% 1951

Federation des caisses Desjardins du Quebec's KERX Position: Q4 2018 in Review

Federation des caisses Desjardins du Quebec sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 465 shares — an estimated $1.58K sold.

Federation des caisses Desjardins du Quebec first reported a position in KERX in Q2 2017 and held it in 6 quarters. The position peaked at $3.36K in Q2 2017. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.

  • Federation des caisses Desjardins du Quebec reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
  • Federation des caisses Desjardins du Quebec sold 465 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $1.58K.
  • Federation des caisses Desjardins du Quebec first reported a position in Keryx Biopharmaceuticals Inc in Q2 2017 and held it in 6 quarters.
  • Federation des caisses Desjardins du Quebec's Keryx Biopharmaceuticals Inc position peaked at $3.36K in Q2 2017.
  • 1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q4 2018, filed 30 Aug 2024.